ストックスクリーナーアプリを入手
0.9665
1.37%
-0.0134
プレマーケット:
1.01
0.0435
+4.50%
Sunshine Biopharma Inc (SBFM) 最新ニュース
SBFM Forecast, Price Target & Analyst Ratings | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) - ChartMill
SBFM (Sunshine Biopharma Inc.) posts wider than expected Q4 2025 loss even as its stock edges higher today. - Xã Thanh Hà
SBFM (Sunshine Biopharma Inc.) rises 3.2 percent despite wider than expected Q4 2025 quarterly per share losses.Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Tây Ninh
SBFM Financials: Income Statement, Balance Sheet & Cash Flow | Sunshine Biopharma Inc - Stock Titan
Sunshine Biopharma Inc. Warrant (SBFMW) - Minichart
SBFM Director Natan David Acquires 100K Shares – April 15, 2026 - Meyka
Director Natan David receives 100,000 SBFM shares in stock award - Stock Titan
Returns Recap: What is Sunshine Biopharma Incs valuation compared to sector2026 Big Picture & Low Risk Investment Opportunities - baoquankhu1.vn
US Market Recap: Is Sunshine Biopharma Incs ROE strong enough2026 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Smart Money: What is Sunshine Biopharma Incs valuation compared to sectorTrade Exit Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Sunshine Biopharma Posts Modest 2025 Revenue Growth and Tightens Costs to Pursue Profitability - TipRanks
Sunshine Biopharma (NASDAQ: SBFM) details 2025 results and cost cuts - Stock Titan
SBFM Reports Increased Revenue and Outlines Future Growth Plans - GuruFocus
Sunshine Biopharma (SBFM) Aims for Cost Reductions to Enhance Pr - GuruFocus
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - ACCESS Newswire
Sunshine Biopharma launched nine new drugs as 2025 sales hit $36.3M - Stock Titan
Sunshine Biopharma Inc. 2025 Annual Report: Generic Drug Portfolio, Proprietary Oncology & Antiviral Developments, and Corporate Strategy - Minichart
SBFM SEC FilingsSunshine Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sunshine Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M - Stock Titan
Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS - TradingView — Track All Markets
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SBFMW Stock Analysis: Sunshine Biopharma Inc Warrant 0.13 Flat Performance Review - Cổng thông tin điện tử tỉnh Lào Cai
Aug Reactions: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Sunshine Biopharma Delays Annual SEC Filing - TipRanks
[NT 10-K] Sunshine Biopharma Inc. SEC Filing - Stock Titan
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
Aug Wrap: Does Sunshine Biopharma Inc Equity Warrant stock have upside surprise potential - baoquankhu1.vn
Bear Alert: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Volume Leaders & Safe Capital Investment Plans - baoquankhu1.vn
Smart Money: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesTrend Reversal & Weekly Top Gainers Alerts - baoquankhu1.vn
Sunshine Biopharma Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Guidance Update: What is the cash position of Sunshine Biopharma Inc Equity Warrant2026 Retail & Low Risk Entry Point Tips - baoquankhu1.vn
Sunshine Biopharma, Inc.: Fundamental Analysis and Financial Ratings | | US8677811064 - marketscreener.com
Revenue per share of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Sunshine Biopharma's March Milestone: A Strategic Financial Review () - aktiencheck.de
Returns Recap: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Sunshine Biopharma Engages Aegis for Warrant Solicitation - TipRanks
Sunshine Biopharma engages Aegis for three-month warrant solicitation, 10% fee on proceeds - TradingView
Sunshine Biopharma (SBFM) taps Aegis to solicit exercises of outstanding warrants - Stock Titan
Risk Check: Will Sunshine Biopharma Inc outperform its industry peersTrade Analysis Summary & Community Verified Trade Signals - baoquankhu1.vn
Sunshine Biopharma (SBFM) Board May Effect Up-to 1-for-10 Reverse Split - Stock Titan
SBFM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Gainers: Is Sunshine Biopharma Incs ROE strong enoughJuly 2025 Retail & Weekly High Momentum Picks - baoquankhu1.vn
Aug Retail: Is Sunshine Biopharma Inc Equity Warrant affected by consumer sentimentWeekly Stock Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Fund Flows: What is the Moat Score of Sunshine Biopharma IncTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Market Review: What is Sunshine Biopharma Incs valuation compared to sector2025 Historical Comparison & Expert Verified Movement Alerts - baoquankhu1.vn
SBFMW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SBFM (Sunshine Biopharma) Total Inventories : $14.06 Mil (As of Sep. 2025) - GuruFocus
Sunshine Biopharma board authorized to consider reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma board authorized to consider reverse stock split - Investing.com
Sunshine Biopharma Shareholders Approve Potential Reverse Stock Split - TipRanks
Sunshine Biopharma (SBFM) majority holder clears path for up to 1-for-10 reverse split - Stock Titan
Weekly Earnings: Will Sunshine Biopharma Inc. outperform its industry peersDollar Strength & High Win Rate Trade Alerts - mfd.ru
1.58%
2.43%
大文字化:
|
ボリューム (24 時間):